INVESCO LTD (IVZ) Fundamental Analysis & Valuation

NYSE:IVZ • BMG491BT1088

Current stock price

23.2 USD
-0.9 (-3.73%)
At close:
23.2 USD
0 (0%)
After Hours:

This IVZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. IVZ Profitability Analysis

1.1 Basic Checks

  • IVZ had positive earnings in the past year.
  • In the past year IVZ had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: IVZ reported negative net income in multiple years.
  • In the past 5 years IVZ always reported a positive cash flow from operatings.
IVZ Yearly Net Income VS EBIT VS OCF VS FCFIVZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

1.2 Ratios

  • With a Return On Assets value of -2.68%, IVZ is not doing good in the industry: 78.66% of the companies in the same industry are doing better.
  • IVZ's Return On Equity of -5.94% is on the low side compared to the rest of the industry. IVZ is outperformed by 74.48% of its industry peers.
Industry RankSector Rank
ROA -2.68%
ROE -5.94%
ROIC N/A
ROA(3y)-0.61%
ROA(5y)0.94%
ROE(3y)-1.51%
ROE(5y)1.79%
ROIC(3y)N/A
ROIC(5y)N/A
IVZ Yearly ROA, ROE, ROICIVZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • In the last couple of years the Operating Margin of IVZ has declined.
  • Looking at the Gross Margin, with a value of 66.64%, IVZ is in the better half of the industry, outperforming 75.31% of the companies in the same industry.
  • IVZ's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for IVZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.64%
OM growth 3Y-8%
OM growth 5Y-4.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.06%
GM growth 5Y-0.49%
IVZ Yearly Profit, Operating, Gross MarginsIVZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. IVZ Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for IVZ has been reduced compared to 1 year ago.
  • IVZ has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, IVZ has a worse debt to assets ratio.
IVZ Yearly Shares OutstandingIVZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
IVZ Yearly Total Debt VS Total AssetsIVZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 0.87, we must say that IVZ is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of IVZ (0.87) is comparable to the rest of the industry.
  • The Debt to FCF ratio of IVZ is 6.51, which is on the high side as it means it would take IVZ, 6.51 years of fcf income to pay off all of its debts.
  • IVZ has a Debt to FCF ratio of 6.51. This is in the better half of the industry: IVZ outperforms 64.44% of its industry peers.
  • IVZ has a Debt/Equity ratio of 0.77. This is a neutral value indicating IVZ is somewhat dependend on debt financing.
  • IVZ has a better Debt to Equity ratio (0.77) than 61.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 6.51
Altman-Z 0.87
ROIC/WACCN/A
WACCN/A
IVZ Yearly LT Debt VS Equity VS FCFIVZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 0.80 indicates that IVZ may have some problems paying its short term obligations.
  • IVZ's Current ratio of 0.80 is on the low side compared to the rest of the industry. IVZ is outperformed by 64.02% of its industry peers.
  • A Quick Ratio of 0.80 indicates that IVZ may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.80, IVZ is doing worse than 63.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
IVZ Yearly Current Assets VS Current LiabilitesIVZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. IVZ Growth Analysis

3.1 Past

  • IVZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.02%, which is quite good.
  • Measured over the past 5 years, IVZ shows a small growth in Earnings Per Share. The EPS has been growing by 0.91% on average per year.
  • Looking at the last year, IVZ shows a small growth in Revenue. The Revenue has grown by 5.11% in the last year.
  • IVZ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.74% yearly.
EPS 1Y (TTM)18.02%
EPS 3Y6.51%
EPS 5Y0.91%
EPS Q2Q%19.23%
Revenue 1Y (TTM)5.11%
Revenue growth 3Y1.78%
Revenue growth 5Y0.74%
Sales Q2Q%8.79%

3.2 Future

  • Based on estimates for the next years, IVZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.74% on average per year.
  • IVZ is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.71% yearly.
EPS Next Y33.52%
EPS Next 2Y22.98%
EPS Next 3Y20.94%
EPS Next 5Y12.74%
Revenue Next Year13.55%
Revenue Next 2Y9.56%
Revenue Next 3Y26.71%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IVZ Yearly Revenue VS EstimatesIVZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B
IVZ Yearly EPS VS EstimatesIVZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. IVZ Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.43, which indicates a very decent valuation of IVZ.
  • The rest of the industry has a similar Price/Earnings ratio as IVZ.
  • IVZ's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.88.
  • The Price/Forward Earnings ratio is 8.56, which indicates a very decent valuation of IVZ.
  • Based on the Price/Forward Earnings ratio, IVZ is valued a bit cheaper than 72.80% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. IVZ is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.43
Fwd PE 8.56
IVZ Price Earnings VS Forward Price EarningsIVZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, IVZ is valued a bit cheaper than 79.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.14
EV/EBITDA N/A
IVZ Per share dataIVZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • IVZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • IVZ's earnings are expected to grow with 20.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.34
PEG (5Y)12.54
EPS Next 2Y22.98%
EPS Next 3Y20.94%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. IVZ Dividend Analysis

5.1 Amount

  • IVZ has a Yearly Dividend Yield of 3.60%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 6.73, IVZ has a dividend in line with its industry peers.
  • IVZ's Dividend Yield is rather good when compared to the S&P500 average which is at 1.90.
Industry RankSector Rank
Dividend Yield 3.6%

5.2 History

  • The dividend of IVZ has a limited annual growth rate of 0.02%.
  • IVZ has paid a dividend for at least 10 years, which is a reliable track record.
  • IVZ has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.02%
Div Incr Years3
Div Non Decr Years3
IVZ Yearly Dividends per shareIVZ Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • The earnings of IVZ are negative and hence is the payout ratio. IVZ will probably not be able to sustain this dividend level.
  • IVZ's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-80.12%
EPS Next 2Y22.98%
EPS Next 3Y20.94%
IVZ Yearly Income VS Free CF VS DividendIVZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

More info and screens

Find the best dividend stocksShow peers with best dividend

IVZ Fundamentals: All Metrics, Ratios and Statistics

INVESCO LTD

NYSE:IVZ (3/27/2026, 8:26:57 PM)

After market: 23.2 0 (0%)

23.2

-0.9 (-3.73%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)01-27
Earnings (Next)04-20
Inst Owners93.79%
Inst Owner Change3.54%
Ins Owners0.65%
Ins Owner Change1.29%
Market Cap10.29B
Revenue(TTM)6.38B
Net Income(TTM)-726.30M
Analysts72.94
Price Target31.9 (37.5%)
Short Float %4.16%
Short Ratio2.49
Dividend
Industry RankSector Rank
Dividend Yield 3.6%
Yearly Dividend1.3
Dividend Growth(5Y)0.02%
DP-80.12%
Div Incr Years3
Div Non Decr Years3
Ex-Date02-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.55%
Min EPS beat(2)5.66%
Max EPS beat(2)33.45%
EPS beat(4)3
Avg EPS beat(4)9.94%
Min EPS beat(4)-12.91%
Max EPS beat(4)33.45%
EPS beat(8)6
Avg EPS beat(8)5%
EPS beat(12)8
Avg EPS beat(12)2.9%
EPS beat(16)9
Avg EPS beat(16)-0.82%
Revenue beat(2)1
Avg Revenue beat(2)0.07%
Min Revenue beat(2)-0.48%
Max Revenue beat(2)0.62%
Revenue beat(4)1
Avg Revenue beat(4)-0.36%
Min Revenue beat(4)-0.92%
Max Revenue beat(4)0.62%
Revenue beat(8)1
Avg Revenue beat(8)-1.08%
Revenue beat(12)2
Avg Revenue beat(12)0.72%
Revenue beat(16)6
Avg Revenue beat(16)7.38%
PT rev (1m)3.57%
PT rev (3m)18.4%
EPS NQ rev (1m)-0.84%
EPS NQ rev (3m)4.61%
EPS NY rev (1m)0.35%
EPS NY rev (3m)6.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 11.43
Fwd PE 8.56
P/S 1.61
P/FCF 7.14
P/OCF 6.75
P/B 0.84
P/tB N/A
EV/EBITDA N/A
EPS(TTM)2.03
EY8.75%
EPS(NY)2.71
Fwd EY11.68%
FCF(TTM)3.25
FCFY14%
OCF(TTM)3.44
OCFY14.82%
SpS14.37
BVpS27.57
TBVpS-0.39
PEG (NY)0.34
PEG (5Y)12.54
Graham Number35.48
Profitability
Industry RankSector Rank
ROA -2.68%
ROE -5.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.64%
FCFM 22.6%
ROA(3y)-0.61%
ROA(5y)0.94%
ROE(3y)-1.51%
ROE(5y)1.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.69%
ROCE(5y)4.41%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8%
OM growth 5Y-4.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.06%
GM growth 5Y-0.49%
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 6.51
Debt/EBITDA N/A
Cap/Depr 54.07%
Cap/Sales 1.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 0.87
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)60.81%
Cap/Depr(5y)66.84%
Cap/Sales(3y)1.78%
Cap/Sales(5y)2.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.02%
EPS 3Y6.51%
EPS 5Y0.91%
EPS Q2Q%19.23%
EPS Next Y33.52%
EPS Next 2Y22.98%
EPS Next 3Y20.94%
EPS Next 5Y12.74%
Revenue 1Y (TTM)5.11%
Revenue growth 3Y1.78%
Revenue growth 5Y0.74%
Sales Q2Q%8.79%
Revenue Next Year13.55%
Revenue Next 2Y9.56%
Revenue Next 3Y26.71%
Revenue Next 5YN/A
EBIT growth 1Y-183.53%
EBIT growth 3Y-6.36%
EBIT growth 5Y-3.5%
EBIT Next Year35.07%
EBIT Next 3Y12.76%
EBIT Next 5Y7.15%
FCF growth 1Y28.56%
FCF growth 3Y41.34%
FCF growth 5Y5.15%
OCF growth 1Y28.18%
OCF growth 3Y29.45%
OCF growth 5Y4.3%

INVESCO LTD / IVZ Fundamental Analysis FAQ

What is the fundamental rating for IVZ stock?

ChartMill assigns a fundamental rating of 4 / 10 to IVZ.


What is the valuation status of INVESCO LTD (IVZ) stock?

ChartMill assigns a valuation rating of 6 / 10 to INVESCO LTD (IVZ). This can be considered as Fairly Valued.


What is the profitability of IVZ stock?

INVESCO LTD (IVZ) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for IVZ stock?

The Earnings per Share (EPS) of INVESCO LTD (IVZ) is expected to grow by 33.52% in the next year.


Can you provide the dividend sustainability for IVZ stock?

The dividend rating of INVESCO LTD (IVZ) is 5 / 10 and the dividend payout ratio is -80.12%.